Advair Hfa Aerosol, Metered
Product Images NDC 50090-4504

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Advair Hfa (NDC 50090-4504). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Chemical Structure (Advairhfa Spl Graphic 01)

Chemical structure of fluticasone propionate, the active ingredient in ADVAIR HFA for respiratory inhalation.*

FDA Label Image

Salmeterol Chemical Structure (Advairhfa Spl Graphic 02)

Chemical structure of fluticasone propionate and salmeterol xinafoate as found in the ADVAIR HFA inhalation aerosol product. The image depicts the molecular configurations of these active ingredients used in respiratory therapy.*

FDA Label Image

Figure 1. Mean Percent Change From Baseline In Fev1 In Subjects Previously Treated With Either Beta2 Agonists (albuterol Or Salmeterol) Or Inhaled Corticosteroids (trial 1) (Advairhfa Spl Graphic 03)

A line graph depicting the percent change in FEV1 over 12 weeks for different treatments: ADVAIR HFA 45 mcg/21 mcg (two inhalations twice daily), Fluticasone propionate inhalation aerosol 44 mcg (two inhalations twice daily), Salmeterol inhalation aerosol 21 mcg (two inhalations twice daily), and placebo. The graph includes sample sizes at various time points for each treatment group.*

FDA Label Image

Figure 2. Mean Percent Change From Baseline In Morning Peak Expiratory Flow In Subjects Previously Treated With Inhaled Corticosteroids (trial 4) (Advairhfa Spl Graphic 04)

A line graph comparing the percentage change in AM PEF (morning peak expiratory flow) over 12 weeks for three inhaled drug treatments: ADVAIR HFA 230 mcg/21 mcg (two inhalations twice daily), ADVAIR DISKUS 500 mcg/50 mcg (one inhalation twice daily), and Fluticasone propionate inhalation aerosol 220 mcg (two inhalations twice daily). The x-axis represents weeks, and the y-axis shows percentage change in AM PEF. The graph tracks sample sizes for each group at various time points.*

FDA Label Image

Figure 3. Percent Change In Serial 12-hour Fev1 In Subjects Previously Using Either Beta2-agonists (albuterol Or Salmeterol) Or Inhaled Corticosteroids (trial 1) (Advairhfa Spl Graphic 05)

Line graph showing the percentage change in FEV1 (forced expiratory volume) over 12 hours from baseline for different inhalation treatments: ADVAIR HFA 45 mcg/21 mcg, fluticasone propionate inhalation aerosol 44 mcg, salmeterol inhalation aerosol 21 mcg, and placebo. The graph compares pulmonary function changes following two inhalations twice daily in a clinical study.*

FDA Label Image

Figure 4. Percent Change In Serial 12-hour Fev1 In Subjects Previously Using Either Beta2-agonists (albuterol Or Salmeterol) Or Inhaled Corticosteroids (trial 1) (Advairhfa Spl Graphic 06)

Line graph showing the percentage change in FEV1 relative to Day 1 baseline over 12 hours for different treatments: ADVAIR HFA 45 mcg/21 mcg (triangles), fluticasone propionate inhalation aerosol 44 mcg (squares), salmeterol inhalation aerosol 21 mcg (circles), and placebo (diamonds). The x-axis represents time in hours, and the y-axis shows the percentage change from baseline.*

FDA Label Image

Figure A (Advairhfa Spl Graphic 07)

An illustrated diagram of an ADVAIR HFA metered aerosol inhaler showing labeled parts: metal canister, purple plastic actuator, purple mouthpiece, counter, and a light purple cap. The diagram highlights the inhaler's physical components to aid identification and assembly.*

FDA Label Image

Figure B (Advairhfa Spl Graphic 08)

An instructional illustration showing a person removing the protective cap from an ADVAIR HFA metered aerosol inhaler by pulling the cap straight off the mouthpiece with one hand while holding the inhaler with the other hand.*

FDA Label Image

Figure C (Advairhfa Spl Graphic 09)

An instructional diagram showing a person holding an ADVAIR HFA aerosol inhaler in their hand, pressing down on the top to spray the medication. The image highlights the correct finger placement and inhaler orientation for respiratory inhalation use.*

FDA Label Image

Figure D (Advairhfa Spl Graphic 10)

An instructional line drawing showing a hand holding and pressing the top of a metered-dose inhaler, with the number "120" visible on the side of the inhaler canister, likely indicating the number of doses remaining.*

FDA Label Image

Figure E (Advairhfa Spl Graphic 11)

Illustration showing the proper mouthpiece-down position for using ADVAIR HFA aerosol inhaler. The image identifies the inhaler with a purple mouthpiece and a light purple cap, held in a hand ready for use.*

FDA Label Image

Figure F (Advairhfa Spl Graphic 12)

Illustration depicting a person exhaling with the caption 'Breathe out as much air as you can,' indicating instructions for breath control, likely related to the use of an inhalation aerosol product.*

FDA Label Image

Figure G (Advairhfa Spl Graphic 13)

An instructional illustration showing a person holding an inhaler near their mouth. The text 'Push down and breathe in' is displayed with an arrow indicating the pressing action on the inhaler canister and inhaling the medication through the mouth.*

FDA Label Image

Figure H (Advairhfa Spl Graphic 14)

An instructional illustration showing a person rinsing their mouth with water and spitting it out over a sink, with a faucet and a glass of water nearby. This image likely relates to oral hygiene or medication aftercare advice.*

FDA Label Image

Figure I (Advairhfa Spl Graphic 15)

An instructional illustration showing the correct and incorrect use of an inhaler. The top half labeled 'Not blocked' depicts the inhaler spray unobstructed, while the bottom half labeled 'Blocked' shows the inhaler spray being partially blocked.*

FDA Label Image

Figure J (Advairhfa Spl Graphic 16)

An instructional diagram showing a hand using a swab or cotton bud to clean or apply to the mouthpiece of an inhaler device. The illustration includes a circular arrow indicating a swirling or rotating motion on the inhaler mouthpiece area.*

FDA Label Image

Label Image (Lbl500904504)

Label for ADVAIR HFA 115 MCG/21 MCG Inhalation Aerosol by A-S Medication Solutions. The label states the active ingredients fluticasone propionate (115 mcg) and salmeterol xinafoate (21 mcg) per actuation. It instructs to store at 20 to 70 degrees F and keep the inhaler with the mouthpiece down. The product delivers 120 metered actuations and includes dosage instructions and an NDC number 50090-4504-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.